Microbiology, genomics, and clinical significance of the Pseudomonas fluorescens species complex, an unappreciated colonizer of humans

Clinical Microbiology Reviews

Volumn 27, Issue 4, 2014, Pages 927-948

  Scales, Brittan S ^a,b   Dickson, Robert P ^a   Lipuma, John J ^b   Huffnagle, Gary B ^a,b  

^a Division of Pulmonary   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PIGMENT; RNA 16S; RNA POLYMERASE; SIDEROPHORE; VIRULENCE FACTOR;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENETICS; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM ISOLATION; BIOFILM; CLINICAL GENETICS; DISEASE TRANSMISSION; GENOMICS; HUMAN; INFLAMMATORY BOWEL DISEASE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHENOTYPE; PROTEIN STRUCTURE; PSEUDOMONAS FLUORESCENS; QUORUM SENSING; SCANNING ELECTRON MICROSCOPY; SEQUENCE ANALYSIS; CLASSIFICATION; HOST PATHOGEN INTERACTION; PATHOGENICITY; PHYSIOLOGY; PSEUDOMONAS INFECTION; QUANTITATIVE TRAIT;

PSEUDOMONAS FLUORESCENS;

GENOMICS; HOST-PATHOGEN INTERACTIONS; HUMANS; PHENOTYPE; PSEUDOMONAS FLUORESCENS; PSEUDOMONAS INFECTIONS; QUANTITATIVE TRAIT, HERITABLE; VIRULENCE FACTORS;

EID: 84907716417     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00044-14     Document Type: Article

References (235)

1. Diaz PI, Hong BY, Frias-Lopez J, Dupuy AK, Angeloni M, Abusleme L, Terzi E, Ioannidou E, Strausbaugh LD, Dongari-Bagtzoglou A. 2013. Transplantation-associated long-term immunosuppression promotes oral colonization by potentially opportunistic pathogens without impacting other members of the salivary bacteriome. Clin. Vaccine Immunol. 20:920-930. http://dx.doi.org/10.1128/CVI.00734-12.
2. Patel SK, Pratap CB, Verma AK, Jain AK, Dixit VK, Nath G. 2013. Pseudomonas fluorescens-like bacteria from the stomach: a microbiological and molecular study. World J. Gastroenterol. 19:1056-1067. http://dx.doi.org/10.3748/wjg.v19.i7.1056.
3. Dickson RP, Erb-Downward JR, Freeman CM, Walker N, Scales BS, Beck JM, Martinez FJ, Curtis JL, Lama VN, Huffnagle GB. 2014. Changes in the lung microbiome following lung transplantation include the emergence of two distinct Pseudomonas species with distinct clinical associations. PLoS One 9:e97214. http://dx.doi.org/10.1371/journal.pone.0097214.
4. Stenhouse MA, Milner LV. 1992. A survey of cold-growing gram-negative organisms isolated from the skin of prospective blood donors. Transfus. Med. 2:235-237. http://dx.doi.org/10.1111/j.1365-3148.1992.tb00161.x.
5. Wagner J, Short K, Catto-Smith AG, Cameron DJ, Bishop RF, Kirk-wood CD. 2008. Identification and characterisation of Pseudomonas 16S ribosomal DNA from ileal biopsies of children with Crohn’s disease. PLoS One 3:e3578. http://dx.doi.org/10.1371/journal.pone.0003578.
6. Baader A, Garre C. 1887. Ü ber Antagonisten unter den Bacterien. Cor-resp. Bl. Schweiz. Ärzte 13:385-392.
7. Gibaud M, Martin-Dupont P, Dominguez M, Laurentjoye P, Chassa-ing B, Leng B. 1984. Pseudomonas fluorescens septicemia following transfusion of contaminated blood. Presse Med. 13:2583-2584.
8. Hsueh PR, Teng LJ, Pan HJ, Chen YC, Sun CC, Ho SW, Luh KT. 1998. Outbreak of Pseudomonas fluorescens bacteremia among oncology patients. J. Clin. Microbiol. 36:2914-2917.
9. Khabbaz RF, Arnow PM, Highsmith AK, Herwaldt LA, Chou T, Jarvis WR, Lerche NW, Allen JR. 1984. Pseudomonas fluorescens bacteremia from blood transfusion. Am. J. Med. 76:62-68.
10. Murray AE, Bartzokas CA, Shepherd AJ, Roberts FM. 1987. Blood transfusion-associated Pseudomonas fluorescens septicaemia: is this an increasing problem? J. Hosp. Infect. 9:243-248. http://dx.doi.org/10.1016/0195-6701(87)90120-4.
11. Pittman M. 1953. A study of bacteria implicated in transfusion reactions and of bacteria isolated from blood products. J. Lab. Clin. Med. 42:273.
12. Scott J, Boulton FE, Govan JR, Miles RS, McClelland DB, Prowse CV. 1988. A fatal transfusion reaction associated with blood contaminated with Pseudomonas fluorescens. Vox Sang. 54:201-204. http://dx.doi.org/10.1111/j.1423-0410.1988.tb03905.x.
13. Benito N, Mirelis B, Luz Galvez M, Vila M, Lopez-Contreras J, Cotura A, Pomar V, March F, Navarro F, Coll P, Gurgui M. 2012. Outbreak of Pseudomonas fluorescens bloodstream infection in a coronary care unit. J. Hosp. Infect. 82:286-289. http://dx.doi.org/10.1016/j.jhin.2012.09.008.
14. Centers for Disease Control and Prevention. 2005. Pseudomonas bloodstream infections associated with a heparin/saline flush— Missouri, New York, Texas, and Michigan, 2004-2005. MMWR Morb. Mortal. Wkly. Rep. 54:269-272.
15. Centers for Disease Control and Prevention. 2006. Update: delayed onset Pseudomonas fluorescens bloodstream infections after exposure to contaminated heparin flush—Michigan and South Dakota, 2005-2006. MMWR Morb. Mortal. Wkly. Rep. 55:961-963.
16. Gershman MD, Kennedy DJ, Noble-Wang J, Kim C, Gullion J, Kacica M, Jensen B, Pascoe N, Saiman L, McHale J, Wilkins M, Schoon-maker-Bopp D, Clayton J, Arduino M, Srinivasan A. 2008. Multistate outbreak of Pseudomonas fluorescens bloodstream infection after exposure to contaminated heparinized saline flush prepared by a compounding pharmacy. Clin. Infect. Dis. 47:1372-1379. http://dx.doi.org/10.1086/592968.
17. Sarubbi FA, Jr, Wilson B, Lee M, Brokopp C. 1978. Nosocomial meningitis and bacteremia due to contaminated amphotericin B. JAMA 239:416-418.
18. Landers CJ, Cohavy O, Misra R, Yang H, Lin YC, Braun J, Targan SR. 2002. Selected loss of tolerance evidenced by Crohn’s disease-associated immune responses to auto-and microbial antigens. Gastroenterology 123:689-699. http://dx.doi.org/10.1053/gast.2002.35379.
19. Arnott ID, Landers CJ, Nimmo EJ, Drummond HE, Smith BK, Targan SR, Satsangi J. 2004. Sero-reactivity to microbial components in Crohn’s disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Am. J. Gastroenterol. 99:2376-2384. http://dx.doi.org/10.1111/j.1572-0241.2004.40417.x.
20. Iltanen S, Tervo L, Halttunen T, Wei B, Braun J, Rantala I, Honkanen T, Kronenberg M, Cheroutre H, Turovskaya O, Autio V, Ashorn M. 2006. Elevated serum anti-I2 and anti-OmpW antibody levels inchildren with IBD. Inflamm. Bowel Dis. 12:389-394. http://dx.doi.org/10.1097/01.MIB.0000218765.84087.42.
21. Mow WS, Landers CJ, Steinhart AH, Feagan BG, Croitoru K, Seidman E, Greenberg GR, Targan SR. 2004. High-level serum antibodies to bacterial antigens are associated with antibiotic-induced clinical remission in Crohn’s disease: a pilot study. Dig. Dis. Sci. 49:1280-1286. http://dx.doi.org/10.1023/B:DDAS.0000037824.66186.e2.
22. Spivak J, Landers CJ, Vasiliauskas EA, Abreu MT, Dubinsky MC, Papadakis KA, Ippoliti A, Targan SR, Fleshner PR. 2006. Antibodies to I2 predict clinical response to fecal diversion in Crohn’s disease. In-flamm. Bowel Dis. 12:1122-1130. http://dx.doi.org/10.1097/01.mib.0000235833.47423.d7.
23. Silby MW, Cerdeno-Tarraga AM, Vernikos GS, Giddens SR, Jackson RW, Preston GM, Zhang XX, Moon CD, Gehrig SM, Godfrey SA, Knight CG, Malone JG, Robinson Z, Spiers AJ, Harris S, Challis GL, Yaxley AM, Harris D, Seeger K, Murphy L, Rutter S, Squares R, Quail MA, Saunders E, Mavromatis K, Brettin TS, Bentley SD, Hothersall J, Stephens E, Thomas CM, Parkhill J, Levy SB, Rainey PB, Thomson NR. 2009. Genomic and genetic analyses of diversity and plant interactions ofPseudomonasfluorescens. Genome Biol. 10:R51. http://dx.doi.org/10.1186/gb-2009-10-5-r51.
24. Feazel LM, Baumgartner LK, Peterson KL, Frank DN, Harris JK, Pace NR. 2009. Opportunistic pathogens enriched in showerhead biofilms. Proc. Natl. Acad. Sci. U. S. A. 106:16393-16399. http://dx.doi.org/10.1073/pnas.0908446106.
25. Haas D, Defago G. 2005. Biological control of soil-borne pathogens by fluorescent pseudomonads. Nat. Rev. Microbiol. 3:307-319. http://dx.doi.org/10.1038/nrmicro1129.
26. Laursen JB, Nielsen J. 2004. Phenazine natural products: biosynthesis, synthetic analogues, and biological activity. Chem. Rev. 104:1663-1686. http://dx.doi.org/10.1021/cr020473j.
27. Weller DM, Landa BB, Mavrodi OV, Schroeder KL, De La Fuente L, Blouin Bankhead S, Allende Molar R, Bonsall RF, Mavrodi DV, Thomashow LS. 2007. Role of 2,4-diacetylphloroglucinol-producing fluorescent Pseudomonas spp. in the defense of plant roots. Plant Biol. (Stuttg.) 9:4-20. http://dx.doi.org/10.1055/s-2006-924473.
28. Mavrodi DV, Blankenfeldt W, Thomashow LS. 2006. Phenazine compounds in fluorescent Pseudomonas spp. biosynthesis and regulation. Annu. Rev. Phytopathol. 44:417-445. http://dx.doi.org/10.1146/annurev.phyto.44.013106.145710.
29. Ramette A, Moenne-Loccoz Y, Defago G. 2003. Prevalence of fluorescent pseudomonads producing antifungal phloroglucinols and/or hydrogen cyanide in soils naturally suppressive or conducive to tobacco black root rot. FEMS Microbiol. Ecol. 44:35-43. http://dx.doi.org/10.1111/j.1574-6941.2003.tb01088.x.
30. Keel C, Weller DM, Natsch A, Defago G, Cook RJ, Thomashow LS. 1996. Conservation of the 2,4-diacetylphloroglucinol biosynthesis locus among fluorescent Pseudomonas strains from diverse geographic locations. Appl. Environ. Microbiol. 62:552-563.
31. Moynihan JA, Morrissey JP, Coppoolse ER, Stiekema WJ, O’Gara F, Boyd EF. 2009. Evolutionary history of the phl gene cluster in the plant-associated bacterium Pseudomonas fluorescens. Appl. Environ. Micro-biol. 75:2122-2131. http://dx.doi.org/10.1128/AEM.02052-08.
32. Takahashi M, Matsumoto S, Iwasaki S, Yahara I. 1990. Molecular basis for determining the sensitivity of eucaryotes to the antimitotic drug rhizoxin. Mol. Gen. Genet. 222:169-175. http://dx.doi.org/10.1007/BF00633814.
33. Gross H, Loper JE. 2009. Genomics of secondary metabolite production by Pseudomonas spp. Nat. Prod. Rep. 26:1408-1446. http://dx.doi.org/10.1039/b817075b.
34. Tsuruo T, Oh-hara Iida TH, Tsukagoshi S, Sato Z, Matsuda I, Iwasaki S, Okuda S, Shimizu F, Sasagawa K, Fukami M, Fukuda K, Arakawa M. 1986. Rhizoxin, a macrocyclic lactone antibiotic, as a new antitumor agent against human and murine tumor cells and their vincristine-resistant sublines. Cancer Res. 46:381-385.
35. Schnider U, Keel C, Blumer C, Troxler J, Defago G, Haas D. 1995. Amplification of the housekeeping sigma factor in Pseudomonas fluore-scens CHA0 enhances antibiotic production and improves biocontrol abilities. J. Bacteriol. 177:5387-5392.
36. Sarniguet A, Kraus J, Henkels MD, Muehlchen AM, Loper JE. 1995. The sigma factor sigma s affects antibiotic production and biological control activity of Pseudomonas fluorescens Pf-5. Proc. Natl. Acad. Sci. U. S. A. 92:12255-12259. http://dx.doi.org/10.1073/pnas.92.26.12255.
37. Rosenberg K, Bertaux J, Krome K, Hartmann A, Scheu S, Bonkowski M.2009. Soil amoebae rapidly change bacterial community composition in the rhizosphere of Arabidopsis thaliana. ISME J. 3:675-684. http://dx.doi.org/10.1038/ismej.2009.11.
38. Ronn R, McCaig AE, Griffiths BS, Prosser JI. 2002. Impact of protozoan grazingonbacterial community structure insoil microcosms. Appl. Environ. Microbiol. 68:6094-6105. http://dx.doi.org/10.1128/AEM.68.12.6094-6105.2002.
39. Umio S, Kawanishi T, Kamishita T, Mine Y. January 1987. Antifungal composition employing pyrrolnitrin in combination with an imidazole compound. US patent 4636520.
40. Fuller AT, Mellows G, Woolford M, Banks GT, Barrow KD, Chain EB. 1971. Pseudomonic acid: an antibiotic produced by Pseudomonas fluore-scens. Nature 234:416-417. http://dx.doi.org/10.1038/234416a0.
41. Bork K, Brauers J, Kresken M. 1989. Efficacy and safety of 2% mupi-rocin ointment in the treatment of primary and secondary skin infec-tions—an open multicentre trial. Br. J. Clin. Pract. 43:284-288.
42. Strock LL, Lee MM, Rutan RL, Desai MH, Robson MC, Herndon DN, Heggers JP. 1990. Topical Bactroban (mupirocin): efficacy in treating burn wounds infected with methicillin-resistant staphylo-cocci. J. Burn Care Rehabil. 11:454-459. http://dx.doi.org/10.1097/00004630-199009000-00015.
43. Neilands JB. 1981. Iron absorption and transport in microorganisms. Annu. Rev. Nutr. 1:27-46. http://dx.doi.org/10.1146/annurev.nu.01.070181.000331.
44. Youard ZA, Mislin GL, Majcherczyk PA, Schalk IJ, Reimmann C. 2007. Pseudomonas fluorescens CHA0 produces enantio-pyochelin, the optical antipodeofthePseudomonas aeruginosasiderophore pyochelin. J. Biol. Chem. 282:35546-35553. http://dx.doi.org/10.1074/jbc.M707039200.
45. Wuest WM, Sattely ES, Walsh CT. 2009. Three siderophores from one bacterial enzymatic assembly line. J. Am. Chem. Soc. 131:5056-5057. http://dx.doi.org/10.1021/ja900815w.
46. Marchi M, Boutin M, Gazengel K, Rispe C, Gauthier JP, Guillerm-Erckelboudt AY, Lebreton L, Barret M, Daval S, Sarniguet A. 2013. Genomic analysis of the biocontrol strain Pseudomonas fluorescens Pf29Arp with evidence of T3SS and T6SS gene expression on plant roots. Environ. Microbiol. Rep. 5:393-403. http://dx.doi.org/10.1111/1758-2229.12048.
47. Preston GM, Bertrand N, Rainey PB. 2001. Type III secretion in plant growth-promoting Pseudomonas fluorescens SBW25. Mol. Microbiol. 41: 999-1014. http://dx.doi.org/10.1046/j.1365-2958.2001.02560.x.
48. Rezzonico F, Binder C, Defago G, Moenne-Loccoz Y. 2005. The type III secretion system of biocontrol Pseudomonas fluorescens KD targets the phytopathogenic Chromista Pythium ultimum and promotes cucumber protection. Mol. Plant Microbe Interact. 18:991-1001. http://dx.doi.org/10.1094/MPMI-18-0991.
49. Loper JE, Hassan KA, Mavrodi DV, Davis EW, II, Lim CK, Shaffer BT, Elbourne LD, Stockwell VO, Hartney SL, Breakwell K, Henkels MD, Tetu SG, Rangel LI, Kidarsa TA, Wilson NL, van de Mortel JE, Song C, Blumhagen R, Radune D, Hostetler JB, Brinkac LM, Durkin AS, Kluepfel DA, Wechter WP, Anderson AJ, Kim YC, Pierson LS, III, Pierson EA, Lindow SE, Kobayashi DY, Raaijmakers JM, Weller DM, Thomashow LS, Allen AE, Paulsen IT. 2012. Comparative genom-ics of plant-associated Pseudomonas spp.: insights into diversity and inheritance of traits involved in multitrophic interactions. PLoS Genet. 8:e1002784. http://dx.doi.org/10.1371/journal.pgen.1002784.
50. Redondo-Nieto M, Barret M, Morrisey JP, Germaine K, Martinez-Granero F, Barahona E, Navazo A, Sanchez-Contreras M, Moynihan JA, Giddens SR, Coppoolse ER, Muriel C, Stiekema WJ, Rainey PB, Dowling D, O’Gara F, Martin M, Rivilla R. 2012. Genome sequence of the biocontrol strain Pseudomonas fluorescens F113. J. Bacteriol. 194: 1273-1274. http://dx.doi.org/10.1128/JB.06601-11.
51. Barret M, Egan F, Moynihan J, Morrissey JP, Lesouhaitier O, O’Gara F. 2013. Characterization of the SPI-1 and Rsp type three secretion systems in Pseudomonas fluorescens F113. Environ. Microbiol. Rep. 5:377-386. http://dx.doi.org/10.1111/1758-2229.12039.
52. Tuttlebee CM, O’Donnell MJ, Keane CT, Russell RJ, Sullivan DJ, Falkiner F, Coleman DC. 2002. Effective control of dental chair unit waterline biofilm and marked reduction of bacterial contamination of output water using two peroxide-based disinfectants. J. Hosp. Infect. 52:192-205. http://dx.doi.org/10.1053/jhin.2002.1282.
53. Donnarumma G, Buommino E, Fusco A, Paoletti I, Auricchio L, Tufano MA. 2010. Effect of temperature on the shift of Pseudomonas fluorescens from an environmental microorganism to a potential human pathogen. Int. J. Immunopathol. Pharmacol. 23:227-234.
54. Bianciotto V, Andreotti S, Balestrini R, Bonfante P, Perotto S. 2001. Mucoid mutants of the biocontrol strain Pseudomonas fluorescens CHA0 show increased ability in biofilm formation on mycorrhizal and nonmy-corrhizal carrot roots. Mol. Plant Microbe Interact. 14:255-260. http://dx.doi.org/10.1094/MPMI.2001.14.2.255.
55. O’Toole GA, Kolter R. 1998. Initiation of biofilm formation in Pseu-domonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol. Microbiol. 28:449-461. http://dx.doi.org/10.1046/j.1365-2958.1998.00797.x.
56. Baum MM, Kainovic A, O’Keeffe T, Pandita R, McDonald K, Wu S, Webster P. 2009. Characterization of structures in biofilms formed by a Pseudomonas fluorescens isolated from soil. BMC Microbiol. 9:103. http://dx.doi.org/10.1186/1471-2180-9-103.
57. Chapalain A, Rossignol G, Lesouhaitier O, Merieau A, Gruffaz C, Guerillon J, Meyer JM, Orange N, Feuilloley MG. 2008. Comparative study of 7 fluorescent pseudomonad clinical isolates. Can. J. Microbiol. 54:19-27. http://dx.doi.org/10.1139/W07-110.
58. Rossignol G, Sperandio D, Guerillon J, Duclairoir Poc C, Soum-Soutera E, Orange N, Feuilloley MG, Merieau A. 2009. Phenotypic variation in the Pseudomonas fluorescens clinical strain MFN1032. Res. Microbiol. 160:337-344. http://dx.doi.org/10.1016/j.resmic.2009.04.004.
59. Sperandio D, Decoin V, Latour X, Mijouin L, Hillion M, Feuilloley MG, Orange N, Merieau A. 2012. Virulence of the Pseudomonas fluore-scens clinical strain MFN1032 towards Dictyostelium discoideum and macrophages in relation with type III secretion system. BMC Microbiol. 12:223. http://dx.doi.org/10.1186/1471-2180-12-223.
60. Almeida LA, Araujo R. 2013. Highlights on molecular identification of closely related species. Infect. Genet. Evol. 13:67-75. http://dx.doi.org/10.1016/j.meegid.2012.08.011.
61. Konstantinidis KT, Ramette A, Tiedje JM. 2006. Toward a more robust assessment of intraspecies diversity, using fewer genetic markers. Appl. Environ. Microbiol. 72:7286-7293. http://dx.doi.org/10.1128/AEM.01398-06.
62. Moore ERB, Tindall BJ, Dos Santos VAPM, Pieper DH, Ramos JL, Palleron NJ. 2006. Nonmedical: Pseudomonas, p 646-703. In Dworkin M, Falkow S, Rosenberg E, Schleifer K-H, Stackebrandt E (ed), Pro-karyotes: a handbook on the biology of bacteria, vol 6, 3rd ed. Springer, New York, NY.
63. Howell C, Stipanovic R. 1980. Suppression of Pythium ultimum-induced damping-off of cotton seedlings by Pseudomonas fluorescens and its antibiotic, pyoluteorin. Phytopathology 70:712-715. http://dx.doi.org/10.1094/Phyto-70-712.
64. De Souza JT, De Boer M, De Waard P, Van Beek TA, Raaijmakers JM. 2003. Biochemical, genetic, and zoosporicidal properties of cyclic lipo-peptide surfactants produced by Pseudomonas fluorescens. Appl. Environ. Microbiol. 69:7161-7172. http://dx.doi.org/10.1128/AEM.69.12.7161-7172.2003.
65. Valverde C, Heeb S, Keel C, Haas D. 2003. RsmY, a small regulatory RNA, is required in concert with RsmZ for GacA-dependent expression of biocontrol traits in Pseudomonas fluorescens CHA0. Mol. Microbiol. 50:1361-1379. http://dx.doi.org/10.1046/j.1365-2958.2003.03774.x.
66. Cosson P, Soldati T. 2008. Eat, kill or die: when amoeba meets bacteria. Curr. Opin. Microbiol. 11:271-276. http://dx.doi.org/10.1016/j.mib.2008.05.005.
67. King EO, Ward MK, Raney DE. 1954. Two simple media for the demonstration of pyocyanin and fluorescin. J. Lab. Clin. Med. 44:301-307.
68. Lowbury EJ, Collins AG. 1955. The use of a new cetrimide product in a selective medium for Pseudomonas pyocyanea. J. Clin. Pathol. 8:47-48. http://dx.doi.org/10.1136/jcp.8.1.47.
69. Bunker ST, Bates TC, Oliver JD. 2004. Effects of temperature on de-tectionofplasmid or chromosomally encoded gfp-and lux-labeled Pseu-domonasfluorescensin soil. Environ. Biosafety Res. 3:83-90. http://dx.doi.org/10.1051/ebr:2004008.
70. Oliver J. 1993. Formation of viable but nonculturable cells, p 239-272. In Kjelleberg S(ed), Starvationin bacteria. Plenum Press, New York, NY.
71. Rowan N. 2004. Viable but non-culturable forms of food and water-borne bacteria: quo vadis? Trends Food Sci. Technol. 15:462-467. http://dx.doi.org/10.1016/j.tifs.2004.02.009.
72. Oliver JD. 1995. The viable but non-culturable state in the human pathogen Vibrio vulnificus. FEMS Microbiol. Lett. 133:203-208. http://dx.doi.org/10.1111/j.1574-6968.1995.tb07885.x.
73. Oliver JD. 2005. The viable but nonculturable state in bacteria. J. Micro-biol. 43(Spec Issue):93-100.
74. Mulet M, Lalucat J, Garcia-Valdes E. 2010. DNA sequence-based analysis of the Pseudomonas species. Environ. Microbiol. 12:1513-1530. http://dx.doi.org/10.1111/j.1462-2920.2010.02181.x.
75. Peix A, Ramirez-Bahena MH, Velazquez E. 2009. Historical evolution and current status of the taxonomy of genus Pseudomonas. Infect. Genet. Evol. 9:1132-1147. http://dx.doi.org/10.1016/j.meegid.2009.08.001.
76. Anzai Y, Kim H, Park JY, Wakabayashi H, Oyaizu H. 2000. Phy-logenetic affiliation of the pseudomonads based on 16S rRNA sequence. Int. J. Syst. Evol. Microbiol. 50:1563-1589. http://dx.doi.org/10.1099/00207713-50-4-1563.
77. Palleroni NJ. 2010. The Pseudomonas story. Environ. Microbiol. 12: 1377-1383. http://dx.doi.org/10.1111/j.1462-2920.2009.02041.x.
78. Palleroni NJ. 2008. The road to the taxonomy of Pseudomonas, p 1-18. In Cornelis P (ed), Pseudomonas. Genomics and molecular biology. Caister Academic Press, Norfolk, United Kingdom.
79. Moore ERB, Mau M, Arnscheidt A, Bottger EC, Hutson RA, Collins MD, Peer YVD, Wachter RD, Timmis KN. 1996. The determination and comparison of the 16S rRNA gene sequences of species of the genus Pseudomonas (sensu stricto) and estimation of the natural intrageneric relationships. Syst. Appl. Microbiol. 1:478-492.
80. Yamamoto S, Kasai H, Arnold DL, Jackson RW, Vivian A, Harayama S. 2000. Phylogeny of the genus Pseudomonas: intrageneric structure reconstructed from the nucleotide sequences of gyrB and rpoD genes. Microbiology 146:2385-2394.
81. Urwin R, Maiden MC. 2003. Multi-locus sequence typing: a tool for global epidemiology. Trends Microbiol. 11:479-487. http://dx.doi.org/10.1016/j.tim.2003.08.006.
82. Chan MS, Maiden MC, Spratt BG. 2001. Database-driven multi locus sequence typing (MLST) of bacterial pathogens. Bioinformatics 17: 1077-1083. http://dx.doi.org/10.1093/bioinformatics/17.11.1077.
83. Sullivan CB, Diggle MA, Clarke SC. 2005. Multilocus sequence typing: data analysisin clinical microbiology and public health. Mol. Biotechnol. 29:245-254. http://dx.doi.org/10.1385/MB:29:3:245.
84. Byun R, Elbourne LD, Lan R, Reeves PR. 1999. Evolutionary relation-shipsof pathogenic clones ofVibrio cholerae bysequence analysisof four housekeeping genes. Infect. Immun. 67:1116-1124.
85. Savli H, Karadenizli A, Kolayli F, Gundes S, Ozbek U, Vahaboglu H. 2003. Expression stability of six housekeeping genes: a proposal for resistance gene quantification studies of Pseudomonas aeruginosa by realtime quantitative RT-PCR. J. Med. Microbiol. 52:403-408. http://dx.doi.org/10.1099/jmm.0.05132-0.
86. Dagerhamn J, Blomberg C, Browall S, Sjostrom K, Morfeldt E, Hen-riques-Normark B. 2008. Determination of accessory gene patterns predicts the same relatedness among strains of Streptococcus pneumoniae as sequencing of housekeeping genes does and represents a novel approach in molecular epidemiology. J. Clin. Microbiol. 46:863-868. http://dx.doi.org/10.1128/JCM.01438-07.
87. Adekambi T, Drancourt M, Raoult D. 2009. The rpoB gene as a tool for clinical microbiologists. Trends Microbiol. 17:37-45. http://dx.doi.org/10.1016/j.tim.2008.09.008.
88. Tayeb LA, Lefevre M, Passet V, Diancourt L, Brisse S, Grimont PA. 2008. Comparative phylogenies of Burkholderia, Ralstonia, Comamo-nas, Brevundimonas and related organisms derived from rpoB, gyrB and rrs gene sequences. Res. Microbiol. 159:169-177. http://dx.doi.org/10.1016/j.resmic.2007.12.005.
89. van Passel MW, Kuramae EE, Luyf AC, Bart A, Boekhout T. 2006. The reach ofthe genome signature inprokaryotes. BMC Evol. Biol. 6:84. http://dx.doi.org/10.1186/1471-2148-6-84.
90. Goris J, Konstantinidis KT, Klappenbach JA, Coenye T, Vandamme P, Tiedje JM. 2007. DNA-DNA hybridization values and their relationship to whole-genome sequence similarities. Int. J. Syst. Evol. Microbiol. 57: 81-91. http://dx.doi.org/10.1099/ijs.0.64483-0.
91. Pearson WR. 2014. BLAST and FASTA similarity searching for multiple sequence alignment. Methods Mol. Biol. 1079:75-101. http://dx.doi.org/10.1007/978-1-62703-646-7_5.
92. Salmond GP, Reeves PJ. 1993. Membrane traffic wardens and protein secretion in gram-negative bacteria. Trends Biochem. Sci. 18:7-12. http://dx.doi.org/10.1016/0968-0004(93)90080-7.
93. Cornelis P. 2010. Iron uptake and metabolism in pseudomonads. Appl. Microbiol. Biotechnol. 86:1637-1645. http://dx.doi.org/10.1007/s00253-010-2550-2.
94. Cornelis P, Matthijs S, Van Oeffelen L. 2009. Iron uptake regulation in Pseudomonas aeruginosa. Biometals 22:15-22. http://dx.doi.org/10.1007/s10534-008-9193-0.
95. Katoh K, Standley DM. 2013. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol. Biol. Evol. 30:772-780. http://dx.doi.org/10.1093/molbev/mst010.
96. Katoh K, Frith MC. 2012. Adding unaligned sequences into an existing alignment using MAFFT and LAST. Bioinformatics 28:3144-3146. http://dx.doi.org/10.1093/bioinformatics/bts578.
97. Katoh K, Kuma K, Toh H, Miyata T. 2005. MAFFT version 5: improvement in accuracy of multiple sequence alignment. Nucleic Acids Res. 33:511-518. http://dx.doi.org/10.1093/nar/gki198.
98. Katoh K, Misawa K, Kuma K, Miyata T. 2002. MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res. 30:3059-3066. http://dx.doi.org/10.1093/nar/gkf436.
99. Botha P, Archer L, Anderson RL, Lordan J, Dark JH, Corris PA, Gould K, Fisher AJ. 2008. Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis ob-literans syndrome. Transplantation 85:771-774. http://dx.doi.org/10.1097/TP.0b013e31816651de.
100. Vos R, Vanaudenaerde BM, Geudens N, Dupont LJ, Van Raemdonck DE, Verleden GM. 2008. Pseudomonal airway colonisation: risk factor for bronchiolitis obliterans syndrome after lung transplantation? Eur. Respir. J. 31:1037-1045. http://dx.doi.org/10.1183/09031936.00128607.
101. Gottlieb J, Mattner F, Weissbrodt H, Dierich M, Fuehner T, Strueber M, Simon A, Welte T. 2009. Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bron-chiolitis obliterans syndrome in recipients with cystic fibrosis. Respir. Med. 103:743-749. http://dx.doi.org/10.1016/j.rmed.2008.11.015.
102. Willner DL, Hugenholtz P, Yerkovich ST, Tan ME, Daly JN, Lachner N, Hopkins PM, Chambers DC. 2013. Reestablishment of recipient-associated microbiota in the lung allograft is linked to reduced risk of bronchiolitis obliterans syndrome. Am. J. Respir. Crit. Care Med. 187: 640-647. http://dx.doi.org/10.1164/rccm.201209-1680OC.
103. Enderby B, Smith D, Carroll W, Lenney W. 2009. Hydrogen cyanide as a biomarker for Pseudomonas aeruginosa in the breath of children with cystic fibrosis. Pediatr. Pulmonol. 44:142-147. http://dx.doi.org/10.1002/ppul.20963.
104. Laville J, Blumer C, Von Schroetter C, Gaia V, Defago G, Keel C, Haas D. 1998. Characterization of the hcnABC gene cluster encoding hydrogen cyanide synthase and anaerobic regulation by ANR in the strictly aerobic biocontrol agent Pseudomonas fluorescens CHA0. J. Bacteriol. 180:3187-3196.
105. Partida-Martinez LP, Hertweck C. 2005. Pathogenic fungus harbours endosymbiotic bacteria for toxin production. Nature 437:884-888. http://dx.doi.org/10.1038/nature03997.
106. Tekeda R. 1958. Pseudomonas pigments. I. Pyoluteorin, a new chlorine-containing pigment produced by Pseudomonas aeruginosa. Hakko Kogaku Zasshi 36:281-290.
107. Ligon JM, Hill DS, Hammer PE, Torkewitz NR, Hofmann D, Kempf H, Pee H. 2000. Natural products with antifungal activity from Pseudomonas biocontrol bacteria. Pest Manag. Sci. 56:688-695. http://dx.doi.org/10.1002/1526-4998(200008)56:8< 688::AID-PS186 >3.0.CO;2-V.
108. Hothersall J, Wu J, Rahman AS, Shields JA, Haddock J, Johnson N, Cooper SM, Stephens ER, Cox RJ, Crosby J, Willis CL, Simpson TJ, Thomas CM. 2007. Mutational analysis reveals that all tailoring region genes are required for production of polyketide antibiotic mupirocin by Pseudomonas fluorescens: pseudomonic acid B biosynthesis precedes pseudomonic acid A. J. Biol. Chem. 282:15451-15461. http://dx.doi.org/10.1074/jbc.M701490200.
109. Sutherland R, Boon RJ, Griffin KE, Masters PJ, Slocombe B, White AR. 1985. Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use. Antimicrob. Agents Chemother. 27:495-498. http://dx.doi.org/10.1128/AAC.27.4.495.
110. Villiger JW, Robertson WD, Kanji K, Ah Chan M, Fetherston J, Hague IK, Haycock D, Hunter P. 1986. A comparison of the new topical antibiotic mupirocin (‘Bactroban’) with oral antibiotics in the treatment of skin infections in general practice. Curr. Med. Res. Opin. 10:339-345. http://dx.doi.org/10.1185/03007998609111100.
111. Odom RB. 1989. Mupirocin (2 percent) ointment in the treatment of primary and secondary skin infections. Cutis 43:599-601.
112. Mertz PM, Marshall DA, Eaglstein WH, Piovanetti Y, Montalvo J. 1989. Topical mupirocin treatment of impetigo is equal to oral erythromycin therapy. Arch. Dermatol. 125:1069-1073.
113. Yanagisawa T, Lee JT, Wu HC, Kawakami M. 1994. Relationship of protein structure of isoleucyl-tRNA synthetase with pseudomonic acid resistance of Escherichia coli. A proposed mode of action of pseudomonic acid as an inhibitor of isoleucyl-tRNA synthetase. J. Biol. Chem. 269:24304-24309.
114. Hughes J, Mellows G. 1978. On the mode of action of pseudomonic acid: inhibition of protein synthesis in Staphylococcus aureus. J. Anti-biot. (Tokyo) 31:330-335. http://dx.doi.org/10.7164/antibiotics.31.330.
115. Hughes J, Mellows G. 1980. Interaction of pseudomonic acid A with Escherichia coli B isoleucyl-tRNA synthetase. Biochem. J. 191:209-219.
116. Hughes J, Mellows G, Soughton S. 1980. How does Pseudomonas fluorescens, the producing organism of the antibiotic pseudomonic acid A, avoid suicide? FEBS Lett. 122:322-324. http://dx.doi.org/10.1016/0014-5793(80)80465-0.
117. Hohnadel D, Meyer JM. 1988. Specificity of pyoverdine-mediated iron uptake among fluorescent Pseudomonas strains. J. Bacteriol. 170:4865-4873.
118. Mossialos D, Meyer JM, Budzikiewicz H, Wolff U, Koedam N, Baysse C, Anjaiah V, Cornelis P. 2000. Quinolobactin, a new siderophore of Pseudomonas fluorescens ATCC 17400, the production of which is repressed by the cognate pyoverdine. Appl. Environ. Microbiol. 66:487-492. http://dx.doi.org/10.1128/AEM.66.2.487-492.2000.
119. Mercado-Blanco J, van der Drift KM, Olsson PE, Thomas-Oates JE, van Loon LC, Bakker PA. 2001. Analysis of the pmsCEAB gene cluster involved in biosynthesis of salicylic acid and the siderophore pseudomonine in the biocontrol strain Pseudomonas fluorescens WCS374. J. Bacteriol. 183:1909-1920. http://dx.doi.org/10.1128/JB.183.6.1909-1920.2001.
120. Gennari M, Dragotto F. 1992. A study of the incidence of different fluorescent Pseudomonas species and biovars in the microflora of fresh and spoiled meat and fish, raw milk, cheese, soil and water. J. Appl. Bacteriol. 72:281-288. http://dx.doi.org/10.1111/j.1365-2672.1992.tb01836.x.
121. Andreani NA, Martino ME, Fasolato L, Carraro L, Montemurro F, Mioni R, Bordin P, Cardazzo B. 2014. Tracking the blue: a MLST approach to characterise the Pseudomonas fluorescens group. Food Microbiol. 39:116-126. http://dx.doi.org/10.1016/j.fm.2013.11.012.
122. Lau GW, Hassett DJ, Ran H, Kong F. 2004. The role of pyocyanin in Pseudomonas aeruginosa infection. Trends Mol. Med. 10:599-606. http://dx.doi.org/10.1016/j.molmed.2004.10.002.
123. Laville J, Voisard C, Keel C, Maurhofer M, Defago G, Haas D. 1992. Global control in Pseudomonas fluorescens mediating antibiotic synthesis and suppression of black root rot of tobacco. Proc. Natl. Acad. Sci. U. S. A. 89:1562-1566. http://dx.doi.org/10.1073/pnas.89.5.1562.
124. Maurhofer M, Reimmann C, Schmidli-Sacherer P, Heeb S, Haas D, Defago G. 1998. Salicylic acid biosynthetic genes expressed in Pseudomonas fluorescens strain P3 improve the induction of systemic resistance in tobacco against tobacco necrosis virus. Phytopathology 88:678-684. http://dx.doi.org/10.1094/PHYTO.1998.88.7.678.
125. Sacherer P, Defago G, Haas D. 1994. Extracellular protease and phos-pholipase C are controlled by the global regulatory gene gacA in the biocontrol strain Pseudomonas fluorescens CHA0. FEMS Microbiol. Lett. 116:155-160. http://dx.doi.org/10.1111/j.1574-6968.1994.tb06694.x.
126. Schnider-Keel U, Seematter A, Maurhofer M, Blumer C, Duffy B, Gigot-Bonnefoy C, Reimmann C, Notz R, Defago G, Haas D, Keel C. 2000. Autoinduction of 2,4-diacetylphloroglucinol biosynthesis in the biocontrol agent Pseudomonas fluorescens CHA0 and repression by the bacterial metabolites salicylate and pyoluteorin. J. Bacteriol. 182:1215-1225. http://dx.doi.org/10.1128/JB.182.5.1215-1225.2000.
127. Pessi G, Haas D. 2001. Dual control of hydrogen cyanide biosynthesis by the global activator GacA in Pseudomonas aeruginosa PAO1. FEMS Microbiol. Lett. 200:73-78. http://dx.doi.org/10.1111/j.1574-6968.2001.tb10695.x.
128. Reimmann C, Beyeler M, Latifi A, Winteler H, Foglino M, Lazdunski A, Haas D. 1997. The global activator GacA of Pseudomonas aeruginosa PAO positively controls the production of the autoinducer N-butyryl-homoserine lactone and the formation of the virulence factors pyocya-nin, cyanide, and lipase. Mol. Microbiol. 24:309-319. http://dx.doi.org/10.1046/j.1365-2958.1997.3291701.x.
129. Heeb S, Blumer C, Haas D. 2002. Regulatory RNA as mediator in GacA/RsmA-dependent global control of exoproduct formation in Pseu-domonas fluorescens CHA0. J. Bacteriol. 184:1046-1056. http://dx.doi.org/10.1128/jb.184.4.1046-1056.2002.
130. Argaman L, Hershberg R, Vogel J, Bejerano G, Wagner EG, Margalit H, Altuvia S. 2001. Novel small RNA-encoding genes in the intergenic regions of Escherichia coli. Curr. Biol. 11:941-950. http://dx.doi.org/10.1016/S0960-9822(01)00270-6.
131. Wassarman KM. 2002. Small RNAs in bacteria: diverse regulators of gene expression in response to environmental changes. Cell 109:141-144. http://dx.doi.org/10.1016/S0092-8674(02)00717-1.
132. Storz G. 2002. An expanding universe of noncoding RNAs. Science 296: 1260-1263. http://dx.doi.org/10.1126/science.1072249.
133. Wagner EG, Altuvia S, Romby P. 2002. Antisense RNAs in bacteria and their genetic elements. Adv. Genet. 46:361-398. http://dx.doi.org/10.1016/S0065-2660(02)46013-0.
134. Bassler BL. 2002. Small talk. Cell-to-cell communication inbacteria. Cell 109:421-424. http://dx.doi.org/10.1016/S0092-8674(02)00749-3.
135. Fuqua WC, Winans SC, Greenberg EP. 1994. Quorum sensing in bacteria: the LuxR-LuxI family of cell density-responsive transcriptional regulators. J. Bacteriol. 176:269-275.
136. Daneshvar A, Truelstrup H. 2013. Kinetics of biofilm formation and desiccation survival of Listeria monocytogenes in single and dual species biofilms with Pseudomonas fluorescens, Serratia proteamaculans or She-wanella baltica on food-grade stainless steel surfaces. Biofouling 29: 1253-1268. http://dx.doi.org/10.1080/08927014.2013.835805.
137. Ude S, Arnold DL, Moon CD, Timms-Wilson T, Spiers AJ. 2006. Biofilm formation and cellulose expression among diverse environmental Pseudomonas isolates. Environ. Microbiol. 8:1997-2011. http://dx.doi.org/10.1111/j.1462-2920.2006.01080.x.
138. Bloemberg GV, Lugtenberg BJ. 2001. Molecular basis of plant growth promotion and biocontrol by rhizobacteria. Curr. Opin. Plant Biol. 4:343-350. http://dx.doi.org/10.1016/S1369-5266(00)00183-7.
139. Whitehead NA, Barnard AM, Slater H, Simpson NJ, Salmond GP. 2001. Quorum-sensing in Gram-negative bacteria. FEMS Microbiol. Rev. 25:365-404. http://dx.doi.org/10.1111/j.1574-6976.2001.tb00583.x.
140. El-Sayed AK, Hothersall J, Thomas CM. 2001. Quorum-sensing-dependent regulation of biosynthesis of the polyketide antibiotic mupi-rocin in Pseudomonas fluorescens NCIMB 10586. Microbiology 147: 2127-2139.
141. Laue BE, Jiang Y, Chhabra SR, Jacob S, Stewart GS, Hardman A, Downie JA, O’Gara F, Williams P. 2000. The biocontrol strain Pseudomonas fluo-rescens F113 produces the Rhizobium small bacteriocin, N-(3-hydroxy-7-cis-tetradecenoyl)homoserine lactone, via HdtS, a putative novel N-acylhomoserine lactone synthase. Microbiology 146:2469-2480.
142. Navarro MV, Newell PD, Krasteva PV, Chatterjee D, Madden DR, O’Toole GA, Sondermann H. 2011. Structural basis for c-di-GMP-mediated inside-out signaling controlling periplasmic proteolysis. PLoS Biol. 9:e1000588. http://dx.doi.org/10.1371/journal.pbio.1000588.
143. Newell PD, Yoshioka S, Hvorecny KL, Monds RD, O’Toole GA. 2011. Systematic analysis of diguanylate cyclases that promote biofilm formation by Pseudomonas fluorescens Pf0-1. J. Bacteriol. 193:4685-4698. http://dx.doi.org/10.1128/JB.05483-11.
144. Newell PD, Boyd CD, Sondermann H, O’Toole GA. 2011. A c-di-GMP effector system controls cell adhesion by inside-out signaling and surface protein cleavage. PLoS Biol. 9:e1000587. http://dx.doi.org/10.1371/journal.pbio.1000587.
145. Rosqvist R, Magnusson KE, Wolf-Watz H. 1994. Target cell contact triggers expression and polarized transfer of Yersinia YopE cytotoxin into mammalian cells. EMBO J. 13:964-972.
146. Sory MP, Cornelis GR. 1994. Translocation of a hybrid YopE-adenylate cyclase from Yersinia enterocolitica into HeLa cells. Mol. Microbiol. 14: 583-594. http://dx.doi.org/10.1111/j.1365-2958.1994.tb02191.x.
147. He SY, Nomura K, Whittam TS. 2004. Type III protein secretion mechanism in mammalian and plant pathogens. Biochim. Biophys. Acta 1694:181-206. http://dx.doi.org/10.1016/j.bbamcr.2004.03.011.
148. Lindgren PB, Peet RC, Panopoulos NJ. 1986. Gene cluster of Pseu-domonas syringae pv. “phaseolicola” controls pathogenicity of bean plants and hypersensitivity of nonhost plants. J. Bacteriol. 168:512-522.
149. Gopalan S, Wei W, He SY. 1996. hrp gene-dependent induction of hin1: a plant gene activated rapidly by both harpins and the avrPto gene-mediated signal. Plant J. 10:591-600. http://dx.doi.org/10.1046/j.1365-313X.1996.10040591.x.
150. Tang X, Frederick RD, Zhou J, Halterman DA, Jia Y, Martin GB. 1996. Initiation of plant disease resistance by physical interaction of AvrPto and Pto kinase. Science 274:2060-2063. http://dx.doi.org/10.1126/science.274.5295.2060.
151. Scofield SR, Tobias CM, Rathjen JP, Chang JH, Lavelle DT, Michel-more RW, Staskawicz BJ. 1996. Molecular basis of gene-for-gene specificity in bacterial speck disease of tomato. Science 274:2063-2065. http://dx.doi.org/10.1126/science.274.5295.2063.
152. Leister RT, Ausubel FM, Katagiri F. 1996. Molecular recognition of pathogen attack occurs inside of plant cells in plant disease resistance specified by the Arabidopsis genes RPS2 and RPM1. Proc. Natl. Acad. Sci. U. S. A. 93:15497-15502. http://dx.doi.org/10.1073/pnas.93.26.15497.
153. Ma Q, Zhai Y, Schneider JC, Ramseier TM, Saier MH. 2003. Protein secretion systems of Pseudomonas aeruginosa and P. fluorescens. Biochim. Biophys. Acta 1611:223-233. http://dx.doi.org/10.1016/S0005-2736(03)00059-2.
154. Rainey PB. 1999. Adaptation of Pseudomonas fluorescens to the plant rhizosphere. Environ. Microbiol. 1:243-257. http://dx.doi.org/10.1046/j.1462-2920.1999.00040.x.
155. Jackson RW, Preston GM, Rainey PB. 2005. Genetic characterization of Pseudomonas fluorescens SBW25 rsp gene expression in the phytosphere and in vitro. J. Bacteriol. 187:8477-8488. http://dx.doi.org/10.1128/JB.187.24.8477-8488.2005.
156. Vinatzer BA, Jelenska J, Greenberg JT. 2005. Bioinformatics correctly identifies many type III secretion substrates in the plant pathogen Pseu-domonas syringae and the biocontrol isolate P. fluorescens SBW25. Mol. Plant Microbe Interact. 18:877-888. http://dx.doi.org/10.1094/MPMI-18-0877.
157. Engel J, Balachandran P. 2009. Role of Pseudomonas aeruginosa type III effectors in disease. Curr. Opin. Microbiol. 12:61-66. http://dx.doi.org/10.1016/j.mib.2008.12.007.
158. Shanahan P, O’Sullivan DJ, Simpson P, Glennon JD, O’Gara F. 1992. Isolation of 2,4-diacetylphloroglucinol from a fluorescent pseudomonad and investigationof physiological parameters influencing its production. Appl. Environ. Microbiol. 58:353-358.
159. Cronin D, Moenne-Loccoz Y, Fenton A, Dunne C, Dowling DN, O’Gara F. 1997. Role of 2,4-diacetylphloroglucinol in the interactions of the biocontrol pseudomonad strain F113 with the potato cyst nematode Globodera rostochiensis. Appl. Environ. Microbiol. 63:1357-1361.
160. Barahona E, Navazo A, Martinez-Granero F, Zea-Bonilla T, Perez-Jimenez RM, Martin M, Rivilla R. 2011. Pseudomonas fluorescens F113 mutant with enhanced competitive colonization ability and improved biocontrol activity against fungal root pathogens. Appl. Environ. Micro-biol. 77:5412-5419. http://dx.doi.org/10.1128/AEM.00320-11.
161. Fenton AM, Stephens PM, Crowley J, O’Callaghan M, O’Gara F. 1992. Exploitation of gene(s) involved in 2,4-diacetylphloroglucinol biosynthesis to confer a new biocontrol capability to a Pseudomonas strain. Appl. Environ. Microbiol. 58:3873-3878.
162. Pernthaler J.2005. Predation on prokaryotesin the water column and its ecological implications. Nat. Rev. Microbiol. 3:537-546. http://dx.doi.org/10.1038/nrmicro1180.
163. Neidig N, Paul RJ, Scheu S, Jousset A. 2011. Secondary metabolites of Pseudomonas fluorescens CHA0 drive complex non-trophic interactions with bacterivorous nematodes. Microb. Ecol. 61:853-859. http://dx.doi.org/10.1007/s00248-011-9821-z.
164. Chauhan A, Layton AC, Williams DE, Smartt AE, Ripp S, Karpinets TV, Brown SD, Sayler GS. 2011. Draft genome sequence of the polycy-clic aromatic hydrocarbon-degrading, genetically engineered biolumi-nescent bioreporter Pseudomonas fluorescens HK44. J. Bacteriol. 193: 5009-5010. http://dx.doi.org/10.1128/JB.05530-11.
165. Madi A, Lakhdari O, Blottiere HM, Guyard-Nicodeme M, Le Roux K, Groboillot A, Svinareff P, Dore J, Orange N, Feuilloley MG, Connil N. 2010. The clinical Pseudomonas fluorescens MFN1032 strain exerts a cy-totoxic effect on epithelial intestinal cells and induces interleukin-8 via the AP-1 signaling pathway. BMC Microbiol. 10:215. http://dx.doi.org/10.1186/1471-2180-10-215.
166. Choi HJ, Seo CH, Park SH, Yang H, Do KH, Kim J, Kim HK, Chung DH, Ahn JH, Moon Y. 2011. Involvement of epidermal growth factor receptor-linked signaling responses in Pseudomonas fluorescens-infected alveolar epithelial cells. Infect. Immun. 79:1998-2005. http://dx.doi.org/10.1128/IAI.01232-10.
167. Hirvonen MR, Huttunen K, Roponen M. 2005. Bacterial strains from moldy buildings are highly potent inducers of inflammatory and cyto-toxic effects. Indoor Air 15(Suppl 9):S65-S70. http://dx.doi.org/10.1111/j.1600-0668.2005.00345.x.
168. Richard A, Rossignol G, Comet JP, Bernot G, Guespin-Michel J, Merieau A. 2012. Boolean models of biosurfactants production in Pseu-domonas fluorescens. PLoS One 7:e24651. http://dx.doi.org/10.1371/journal.pone.0024651.
169. Rossignol G, Merieau A, Guerillon J, Veron W, Lesouhaitier O, Feuilloley MG, Orange N. 2008. Involvement of a phospholipase C in the hemolytic activity of a clinical strain of Pseudomonas fluorescens. BMC Microbiol. 8:189. http://dx.doi.org/10.1186/1471-2180-8-189.
170. Sperandio D, Rossignol G, Guerillon J, Connil N, Orange N, Feuilloley MG, Merieau A. 2010. Cell-associated hemolysis activity in the clinical strain of Pseudomonas fluorescens MFN1032. BMC Microbiol. 10:124. http://dx.doi.org/10.1186/1471-2180-10-124.
171. Dacheux D, Goure J, Chabert J, Usson Y, Attree I. 2001. Pore-forming activity oftype III system-secreted proteins leadstooncosis ofPseudomo-nas aeruginosa-infected macrophages. Mol. Microbiol. 40:76-85. http://dx.doi.org/10.1046/j.1365-2958.2001.02368.x.
172. Raaijmakers JM, De Bruijn I, Nybroe O, Ongena M. 2010. Natural functions of lipopeptides from Bacillus and Pseudomonas: more than surfactants and antibiotics. FEMS Microbiol. Rev. 34:1037-1062. http://dx.doi.org/10.1111/j.1574-6976.2010.00221.x.
173. Hallet B. 2001. Playing Dr Jekyll andMr Hyde: combined mechanisms of phase variation in bacteria. Curr. Opin. Microbiol. 4:570-581. http://dx.doi.org/10.1016/S1369-5274(00)00253-8.
174. Hogardt M, Heesemann J. 2013. Microevolution of Pseudomonas aerugi-nosa to a chronic pathogen of the cystic fibrosis lung. Curr. Top. Microbiol. Immunol. 358:91-118. http://dx.doi.org/10.1007/82_2011_199.
175. Anderson M, Davey R. 1994. Pseudobacteraemia with Pseudomonas fluorescens. Med. J. Aust. 160:233-234.
176. Collignon P, Dreimanis D, Beckingham W. 1999. Pseudobacteraemia due to Pseudomonas fluorescens. J. Hosp. Infect. 43:321-322.
177. Gottlieb T, Funnell G, Gosbell I. 1991. Pseudomonas fluorescens pseu-dobacteraemia. Med. J. Aust. 155:854-855.
178. Namnyak S, Hussain S, Davalle J, Roker K, Strickland M. 1999. Contaminated lithium heparin bottles as a source of pseudobacteraemia due to Pseudomonas fluorescens. J. Hosp. Infect. 41:23-28. http://dx.doi.org/10.1016/S0195-6701(99)90033-6.
179. Siebor E, Llanes C, Lafon I, Ogier-Desserrey A, Duez JM, Pechinot A, Caillot D, Grandjean M, Sixt N, Neuwirth C. 2007. Presumed pseudo-bacteremia outbreak resulting from contamination of proportional disinfectant dispenser. Eur. J. Clin. Microbiol. Infect. Dis. 26:195-198. http://dx.doi.org/10.1007/s10096-007-0260-1.
180. Simor AE, Ricci J, Lau A, Bannatyne RM, Ford-Jones L. 1985. Pseu-dobacteremia due to Pseudomonas fluorescens. Pediatr. Infect. Dis. 4:508-512. http://dx.doi.org/10.1097/00006454-198509000-00014.
181. Smith J, Ashhurst-Smith C, Norton R. 2002. Pseudomonas fluorescens pseudobacteraemia: a cautionary lesson. J. Paediatr. Child Health 38:63-65. http://dx.doi.org/10.1046/j.1440-1754.2002.00727.x.
182. Whyte A, Lafong C, Malone J, Golda BP. 1999. Contaminated lithium heparin bottles as a source of pseudobacteraemia. J. Hosp. Infect. 42: 342-343. http://dx.doi.org/10.1053/jhin.1999.0601.
183. Adeyemi AI, Sulaiman AA, Solomon BB, Chinedu OA, Victor IA. 2010. Bacterial bloodstream infections in HIV-infected adults attending a Lagos teaching hospital. J. Health Popul. Nutr. 28:318-326.
184. Bompard Y, Lambert T, Gantzer A, Chastel A, Voinnesson A, Aufrant C. 1988. Use of imipenem-cilastatin in neonatal septicemias caused by gram-negative bacilli multiresistant to beta-lactam antibiotics. Pathol. Biol. (Paris) 36:521-524.
185. Popov DA, Vostrikova T. 2011. The first experience of application of PCR techniques in real-time mode to diagnose bacteremia during postoperational period in cardiosurgery patients. Klin. Lab. Diagn. 2011:49-52.
186. Rais-Bahrami K, Platt P, Naqvi M. 1990. Neonatal pseudomonas sepsis: even early diagnosis is too late. Clin. Pediatr. (Phila.) 29:444. http://dx.doi.org/10.1177/000992289002900804.
187. Rodriguez Ramirez J, Pena Quintana P, Cabrera Galvan JJ, Gomez Diaz J. 1989. Severe intrahepatic cholestasis in sepsis caused by Pseu-domonas fluorescens. Rev. Clin. Esp. 185:106-107.
188. Shah SS, Kagen J, Lautenbach E, Bilker WB, Matro J, Dominguez TE, Tabbutt S, Gaynor JW, Bell LM. 2007. Bloodstream infections after median sternotomy at a children’s hospital. J. Thorac. Cardiovasc. Surg. 133:435-440. http://dx.doi.org/10.1016/j.jtcvs.2006.09.026.
189. Sutter VL. 1968. Identification of Pseudomonas species isolated from hospital environment and human sources. Appl. Microbiol. 16:1532-1538.
190. Brook I. 1987. Microbiology of human and animal bite wounds in children. Pediatr. Infect. Dis. J. 6:29-32. http://dx.doi.org/10.1097/00006454-198701000-00008.
191. Dalamaga M, Karmaniolas K, Chavelas C, Liatis S, Matekovits H, Migdalis I. 2005. Pseudomonas fluorescens cutaneous abscess and recurrent bacteremia following a dog bite. Int. J. Dermatol. 44:347-349. http://dx.doi.org/10.1111/j.1365-4632.2004.02107.x.
192. Carpenter EM, Dicks D. 1982. Isolation of Pseudomonas fluorescens after suprapubic catheterisation. J. Clin. Pathol. 35:581.
193. Pappas G, Karavasilis V, Christou L, Tsianos EV. 2006. Pseudomonas fluorescens infections in clinical practice. Scand. J. Infect. Dis. 38:68-70. http://dx.doi.org/10.1080/00365540500264043.
194. Rutenburg AM, Koota GM, Schweinburg FB. 1958. The efficacy of kanamycin in the treatment of surgical infections. Ann. N. Y. Acad. Sci. 76:348-362.
195. Redding PJ, McWalter PW. 1980. Pseudomonas fluorescens cross-infection due to contaminated humidifier water. Br. Med. J. 281:275.
196. Thangkhiew I. 1986. Successful treatment with ceftazidime of a Pseu-domonas fluorescens chest infection in a myasthenic patient. J. Antimi-crob. Chemother. 18:428-429. http://dx.doi.org/10.1093/jac/18.3.428.
197. Zervos M, Nelson M. 1998. Cefepime versus ceftriaxone for empiric treatment of hospitalized patients with community-acquired pneumonia. The Cefepime Study Group. Antimicrob. Agents Chemother. 42:729-733.
198. Bahrani-Mougeot FK, Paster BJ, Coleman S, Barbuto S, Brennan MT, Noll J, Kennedy T, Fox PC, Lockhart PB. 2007. Molecular analysis of oral and respiratory bacterial species associated with ventilator-associated pneumonia. J. Clin. Microbiol. 45:1588-1593. http://dx.doi.org/10.1128/JCM.01963-06.
199. Klinger JD, Thomassen MJ. 1985. Occurrence and antimicrobial susceptibility of gram-negative nonfermentative bacilli in cystic fibrosis patients. Diagn. Microbiol. Infect. Dis. 3:149-158. http://dx.doi.org/10.1016/0732-8893(85)90025-2.
200. Sutton CL, Kim J, Yamane A, Dalwadi H, Wei B, Landers C, Targan SR, Braun J. 2000. Identification of a novel bacterial sequence associated with Crohn’s disease. Gastroenterology 119:23-31. http://dx.doi.org/10.1053/gast.2000.8519.
201. Dalwadi H, Wei B, Kronenberg M, Sutton CL, Braun J. 2001. The Crohn’s disease-associated bacterial protein I2 is a novel enteric T cell superantigen. Immunity 15:149-158. http://dx.doi.org/10.1016/S1074-7613(01)00164-9.
202. Fukata M, Michelsen KS, Eri R, Thomas LS, Hu B, Lukasek K, Nast CC, Lechago J, Xu R, Naiki Y, Soliman A, Arditi M, Abreu MT. 2005. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 288:G1055-G1065. http://dx.doi.org/10.1152/ajpgi.00328.2004.
203. Wei B, Huang T, Dalwadi H, Sutton CL, Bruckner D, Braun J. 2002. Pseudomonas fluorescens encodes the Crohn’s disease-associated I2 sequence and T-cell superantigen. Infect. Immun. 70:6567-6575. http://dx.doi.org/10.1128/IAI.70.12.6567-6575.2002.
204. Ashorn S, Raukola H, Valineva T, Ashorn M, Wei B, Braun J, Rantala I, Kaukinen K, Luukkaala T, Collin P, Maki M, Iltanen S. 2008. Elevated serum anti-Saccharomyces cerevisiae, anti-I2 and anti-OmpW antibody levels in patients with suspicion of celiac disease. J. Clin. Immunol. 28:486-494. http://dx.doi.org/10.1007/s10875-008-9200-9.
205. Ashorn S, Valineva T, Kaukinen K, Ashorn M, Braun J, Raukola H, Rantala I, Collin P, Maki M, Luukkaala T, Iltanen S. 2009. Serological responses to microbial antigens in celiac disease patients during a gluten-free diet. J. Clin. Immunol. 29:190-195. http://dx.doi.org/10.1007/s10875-008-9255-7.
206. Mundwiler ML, Mei L, Landers CJ, Reveille JD, Targan S, Weisman MH. 2009. Inflammatory bowel disease serologies in ankylosing spon-dylitis patients: a pilot study. Arthritis Res. Ther. 11:R177. http://dx.doi.org/10.1186/ar2866.
207. Yu JE, De Ravin SS, Uzel G, Landers C, Targan S, Malech HL, Holland SM, Cao W, Harpaz N, Mayer L, Cunningham-Rundles C. 2011. High levelsofCrohn’s disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous disease. Clin. Immunol. 138:14-22. http://dx.doi.org/10.1016/j.clim.2010.08.003.
208. Silby MW, Winstanley C, Godfrey SA, Levy SB, Jackson RW. 2011. Pseudomonas genomes: diverse and adaptable. FEMS Microbiol. Rev. 35:652-680. http://dx.doi.org/10.1111/j.1574-6976.2011.00269.x.
209. Katoh K, Toh H. 2008. Recent developments in the MAFFT multiple sequence alignment program. Brief. Bioinform. 9:286-298. http://dx.doi.org/10.1093/bib/bbn013.
210. Kuraku S, Zmasek CM, Nishimura O, Katoh K. 2013. Aleaves facilitates on-demand exploration of metazoan gene family trees on MAFFT sequence alignment server with enhanced interactivity. Nucleic Acids Res. 41:W22-W28. http://dx.doi.org/10.1093/nar/gkt389.
211. Han MV, Zmasek CM. 2009. phyloXML: XML for evolutionary biology and comparative genomics. BMC Bioinformatics 10:356. http://dx.doi.org/10.1186/1471-2105-10-356.
212. Jumpstart Consortium Human Microbiome Project Data Generation Working Group. 2012. Evaluation of 16S rDNA-based community profiling for human microbiome research. PLoS One 7:e39315. http://dx.doi.org/10.1371/journal.pone.0039315.
213. Dubey L, Krasinski K, Hernanz-Schulman M. 1988. Osteomyelitis secondary to trauma or infected contiguous soft tissue. Pediatr. Infect. Dis. J. 7:26-34. http://dx.doi.org/10.1097/00006454-198801000-00007.
214. Hessen MT, Ingerman MJ, Kaufman DH, Weiner P, Santoro J, Kor-zeniowski OM, Boscia J, Topiel M, Bush LM, Kaye D. 1987. Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis. Am. J. Med. 82:262-265.
215. Laguna del Estal P, Castaneda Pastor A, Lopez-Cano Gomez M, Garcia Montero P. 2010. Bacterial meningitis secondary to spinal analgesia and anaesthesia. Neurologia 25:552-556. http://dx.doi.org/10.1016/j.nrl.2010.07.002.
216. Essex RW, Charles PG, Allen PJ. 2004. Three cases of post-traumatic endophthalmitis caused by unusual bacteria. Clin. Exp. Ophthalmol. 32: 445-447. http://dx.doi.org/10.1111/j.1442-9071.2004.00855.x.
217. Kitzmann AS, Goins KM, Syed NA, Wagoner MD. 2008. Bilateral herpes simplex keratitis with unilateral secondary bacterial keratitis and corneal perforation in a patient with pityriasis rubra pilaris. Cornea 27: 1212-1214. http://dx.doi.org/10.1097/ICO.0b013e318180f0a8.
218. Ye JJ, Guo LB, Wang SR, Wang WW, Min HY. 2012. Vitreal surgery and etiological diagnosisofbacterial endophthalmitis. Zhonghua Yan Ke Za Zhi 48:995-1000.
219. Olszewski J, Milonski J. 2008. The analysis of the bacterial and fungal flora in maxillary sinuses in patients operated due to FESS method. Otolaryngol. Pol. 62:458-461. http://dx.doi.org/10.1016/S0030-6657(08)70292-0.
220. Foulon W, Naessens A, Lauwers S, Volckaert M, Devroey P, Amy JJ. 1981. Pelvic inflammatory disease due to Pseudomonas fluorescens in patient wearing an intrauterine device. Lancet ii:358-359.
221. Compeau G, Al-Achi BJ, Platsouka E, Levy SB. 1988. Survival of rifampin-resistant mutants of Pseudomonas fluorescensandPseudomonas putida in soil systems. Appl. Environ. Microbiol. 54:2432-2438.
222. Wilson M, Lindow SE. 1994. Ecological similarity and coexistence of epiphytic Ice-nucleating (Ice) Pseudomonas syringae strains and a non-Ice-nucleating (Ice) biological control agent. Appl. Environ. Microbiol. 60:3128-3137.
223. Pierson EA, Weller DM. 1994. Use of mixtures of fluorescent pseu-domonads to suppress take-all and improve the growth of wheat. Phytopathology 84:940-947. http://dx.doi.org/10.1094/Phyto-84-940.
224. Raaijmakers JM, Weller DM. 1998. Natural plant protection by 2,4-diacetylphloroglucinol-producing Pseudomonas spp. in take-all decline soils. Mol. Plant Microbe Interact. 11:144-152.
225. Banowetz GM, Azevedo MD, Armstrong DJ, Halgren AB, Mills DI. 2008. Germination-arrest factor (GAF): biological properties of a novel, naturally-occurring herbicide produced by selected isolates of rhizo-sphere bacteria. Biol. Control 46:380-390. http://dx.doi.org/10.1016/j.biocontrol.2008.04.016.
226. Kimbrel JA, Givan SA, Halgren AB, Creason AL, Mills DI, Banowetz GM, Armstrong DJ, Chang JH. 2010. An improved, high-quality draft genome sequenceofthe germination-arrest factor-producingPseudomo-nas fluorescens WH6. BMC Genomics 11:522. http://dx.doi.org/10.1186/1471-2164-11-522.
227. Barton MD, Petronio M, Giarrizzo JG, Bowling BV, Barton HA. 2013. The genome of Pseudomonas fluorescens strain R124 demonstrates phe-notypic adaptation to the mineral environment. J. Bacteriol. 195:4793-4803. http://dx.doi.org/10.1128/JB.00825-13.
228. Paulsen IT, Press CM, Ravel J, Kobayashi DY, Myers GS, Mavrodi DV, DeBoy RT, Seshadri R, Ren Q, Madupu R, Dodson RJ, Durkin AS, Brinkac LM, Daugherty SC, Sullivan SA, Rosovitz MJ, Gwinn ML, Zhou L, Schneider DJ, Cartinhour SW, Nelson WC, Weidman J, Watkins K, Tran K, Khouri H, Pierson EA, Pierson LS, III, Thom-ashow LS, Loper JE. 2005. Complete genome sequence of the plant commensal Pseudomonas fluorescens Pf-5. Nat. Biotechnol. 23:873-878. http://dx.doi.org/10.1038/nbt1110.
229. Stutz EW, Défago G, Kern H. 1986. Naturally occurring fluorescent pseudomonads involved in suppression of black root rot of tobacco. Phytopathology 76:181-185. http://dx.doi.org/10.1094/Phyto-76-181.
230. Ramette A, Frapolli M, Fischer-Le Saux M, Gruffaz C, Meyer JM, Defago G, Sutra L, Moenne-Loccoz Y. 2011. Pseudomonas protegens sp. nov., widespread plant-protecting bacteria producing the biocontrol compounds 2,4-diacetylphloroglucinol and pyoluteorin. Syst. Appl. Mi-crobiol. 34:180-188. http://dx.doi.org/10.1016/j.syapm.2010.10.005.
231. Ortet P, Barakat M, Lalaouna D, Fochesato S, Barbe V, Vacherie B, Santaella C, Heulin T, Achouak W. 2011. Complete genome sequence of a beneficial plant root-associated bacterium, Pseudomonas brassi-cacearum. J.Bacteriol.193:3146. http://dx.doi.org/10.1128/JB.00411-11.
232. Harris R, Knowles CJ. 1983. Isolation and growth of a Pseudomonas species that utilizes cyanide as a source of nitrogen. J. Gen. Microbiol. 129:1005-1011.
233. Vilo CA, Benedik MJ, Kunz DA, Dong Q. 2012. Draft genome sequence of the cyanide-utilizing bacterium Pseudomonas fluorescens strain NCIMB 11764. J. Bacteriol. 194:6618-6619. http://dx.doi.org/10.1128/JB.01670-12.
234. Kropp BR, Thomas E, Pounder JI, Anderson AJ. 1996. Increased emergence of spring wheat after inoculation with Pseudomonas chlorora-phis isolate 2E3 under field and laboratory conditions. Biol. Fertil. Soils 23:200-206. http://dx.doi.org/10.1007/BF00336064.
235. Kluepfel DA, McInnis TM, Zehr EI. 1993. Involvement of root-colonizing bacteria in peach orchard soils suppressive of the nematode Criconemella xenoplax. Phytopathology 83:1240-1245. http://dx.doi.org/10.1094/Phyto-83-1240.